Dalton Travis purchased $250K of CTEV (indirect holdings)
Dalton Travis (Pres., CEO & Executive Chair) purchased 6,450 indirectly-held shares of Claritev Corp (CTEV) at an average of $38.71 ($38.48–$38.81, $0.25M total) across 2 trades over 2026-08-27 to 2026-08-28.
How this was made
The 30-second read
Why it matters
The purchase is modest and does not suggest a material shift in insider sentiment.
Market read
A small insider buy with limited trading relevance.
What to watch
No 10b5-1 plan; the purchase may reflect personal liquidity needs.
Background
Form 4 filings disclose insider trades; investors monitor them for signals of confidence.
Ticker impact
CEO Dalton Travis bought 6,450 shares for $249,664, increasing his stake to 52,322 shares.
Minimal short-term price effect; may slightly support bullish sentiment.
The transaction is a routine insider buy under $250K, unlikely to move the stock materially.
Market effects
None; the purchase does not affect the broader sector.
None; limited to the company.
None
Counterpoint
The buy could be a routine portfolio adjustment rather than a strong endorsement.
Key entities
- InsiderDalton Travis
President, CEO & Executive Chair of Claritev Corp.
- CompanyClaritev Corp
US-listed biotech firm (ticker CTEV).